Perioperative indocyanine green clearance is predictive for prolonged intensive care unit stay after coronary artery bypass grafting - an observational study

Critical Care

Volumn 13, Issue 5, 2009, Pages

  Sander, Michael ^a   Spies, Claudia D ^a   Berger, Katharina ^a   Schröder, Torsten ^a   Grubitzsch, Herko ^a   Wernecke, Klaus D ^b   von Heymann, Christian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SOSTANA GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; INDOCYANINE GREEN; LIVER ENZYME; MARKER; COLORING AGENT;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ASSESSMENT; CORONARY ARTERY BYPASS GRAFT; DRUG CLEARANCE; EVIDENCE BASED PRACTICE; HEMATOCRIT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER PERFUSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PERFUSION; PERIOPERATIVE PERIOD; PLASMA CLEARANCE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ANESTHESIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODILUTION; LENGTH OF STAY; LIVER; LIVER CIRCULATION; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; REGRESSION ANALYSIS; STATISTICS;

AGED; ANESTHESIA; COLORING AGENTS; CORONARY ARTERY BYPASS; FEMALE; HEMODILUTION; HUMANS; INDOCYANINE GREEN; INTENSIVE CARE UNITS; LENGTH OF STAY; LIVER; LIVER CIRCULATION; MALE; MIDDLE AGED; PERFUSION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; REGRESSION ANALYSIS;

EID: 77949878398     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8045     Document Type: Article

References (35)

1. Gordon RJ, Ravin M, Rawitscher RE, Daicoff GR. Changes in arterial pressure, viscosity and resistance during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1975, 69:552-561.
2. Bach F, Silomon M, Grundmann U, Sturner J, Graeter T, Larsen R. Splanchnikusperfusion unter Dopexamin bei kardiochirurgischen Eingriffen. Anaesthesist 1999, 48:713-717. 10.1007/s001010050775, 10551920.
3. Ott MJ, Buchman TG, Baumgartner WA. Postoperative abdominal complications in cardiopulmonary bypass patients: a case-controlled study. Ann Thorac Surg 1995, 59:1210-1213. 10.1016/0003-4975(95)00133-6, 7733723.
4. Dantzker DR. The gastrointestinal tract. The canary of the body?. JAMA 1993, 270:1247-1248. 10.1001/jama.270.10.1247, 8355390.
5. Meier-Hellmann A, Reinhart K, Bredle DL, Sakka SG. Therapeutic options for the treatment of impaired gut function. J Am Soc Nephrol 2001, 12(Suppl 17):S65-S69.
6. Tamion F, Richard V, Sauger F, Menard JF, Girault C, Richard JC, Thuillez C, Leroy J, Bonmarchand G. Gastric mucosal acidosis and cytokine release in patients with septic shock. Crit Care Med 2003, 31:2137-2143. 10.1097/01.CCM.0000079600.49048.28, 12973171.
7. Poeze M, Ramsay G, Buurman WA, Greve JW, Dentener M, Takala J. Increased hepatosplanchnic inflammation precedes the development of organ dysfunction after elective high-risk surgery. Shock 2002, 17:451-458. 10.1097/00024382-200206000-00002, 12069179.
8. Fink MP. Adequacy of gut oxygenation in endotoxemia and sepsis. Crit Care Med 1993, 21:S4-S8.
9. Siems W, Kowalewski J, Werner A, Schimke I, Gerber G. Radical formation in the rat small intestine during and following ischemia. Free Radic Res Commun 1989, 7:347-353. 10.3109/10715768909087961, 2583551.
10. Kern H, Schroder T, Kaulfuss M, Martin M, Kox WJ, Spies CD. Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients. Crit Care Med 2001, 29:1519-1525. 10.1097/00003246-200108000-00004, 11505119.
11. Lehmann C, Taymoorian K, Wauer H, Krausch D, Birnbaum J, Kox WJ. Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock. Intensive Care Med 2000, 26:1557-1560. 10.1007/s001340000662, 11126272.
12. Braun JP, Schroeder T, Buehner S, Dohmen P, Moshirzadeh M, Grosse J, Streit F, Schlaefke A, Armstrong VW, Oellerich M, Lochs H, Konertz W, Kox WJ, Spies C. Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass. Acta Anaesthesiol Scand 2004, 48:697-703. 10.1111/j.1399-6576.2004.00392.x, 15196101.
13. Kumle B, Boldt J, Suttner SW, Piper SN, Lehmann A, Blome M. Influence of prolonged cardiopulmonary bypass times on splanchnic perfusion and markers of splanchnic organ function. Ann Thorac Surg 2003, 75:1558-1564. 10.1016/S0003-4975(02)04903-2, 12735579.
14. Birnbaum J, Lehmann C, Taymoorian K, Krausch D, Wauer H, Grundling M, Spies C, Kox WJ. [The effect of dopexamine and iloprost on plasma disappearance rate of indocyanine green in patients in septic shock]. Anaesthesist 2003, 52:1014-1019. 10.1007/s00101-003-0580-1, 14992087.
15. Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002, 122:1715-1720. 10.1378/chest.122.5.1715, 12426276.
16. Sander M, Spies CD, Foer A, Syn DY, Grubitzsch H, Von HC. Peri-operative plasma disappearance rate of indocyanine green after coronary artery bypass surgery. Cardiovasc J Afr 2007, 18:375-379.
17. von Heymann C, Sander M, Foer A, Heinemann A, Spiess B, Braun J, Kramer M, Grosse J, Dohmen P, Dushe S, Halle J, Konertz WF, Wernecke KD, Spies C. The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome - a randomized controlled study [ISRCTN35655335]. Crit Care 2006, 10:R58. 10.1186/cc4891, 1550910, 16606474.
18. Hein OV, Birnbaum J, Wernecke KD, Konertz W, Jain U, Spies C. Three-year survival after four major post-cardiac operative complications. Crit Care Med 2006, 34:2729-2737. 10.1097/01.CCM.0000242519.71319.AD, 16971859.
19. Brunner E, Domhof S, Langer F. Non-parametric analysis of longitudinal data in factorial experiments 2002, New York: John Wiley & Sons.
20. Jakob SM, Ruokonen E, Takala J. Assessment of the adequacy of systemic and regional perfusion after cardiac surgery. Br J Anaesth 2000, 84:571-577.
21. Autschbach R, Falk V, Lange H, Oellerich M, Walther T, Mohr FW, Dalichau H. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass. Thorac Cardiovasc Surg 1996, 44:76-80. 10.1055/s-2007-1011990, 8782332.
22. Uusaro A, Ruokonen E, Takala J. Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br J Anaesth 1995, 74:149-154. 10.1093/bja/74.2.149, 7696062.
23. Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S. Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 2001, 29:1159-1163. 10.1097/00003246-200106000-00014, 11395594.
24. Maynard ND, Bihari DJ, Dalton RN, Beale R, Smithies MN, Mason RC. Liver function and splanchnic ischemia in critically ill patients. Chest 1997, 111:180-187. 10.1378/chest.111.1.180, 8996014.
25. Sakka S, Meier-Hellmann A. Indocyanin Green for Assessment of liver function in Critically Ill Patients. Yearbook of Intensive Care and Emergency Medicine 2001 2001, Berlin-Heidelberg-New York: Springer Verlag.
26. Habler O, Kleen M, Hutter J, Podtschaske A, Tiede M, Kemming G, Corso C, Batra S, Keipert P, Faithfull S, Messmer K. Effects of hemodilution on splanchnic perfusion and hepatorenal function. II. Renal perfusion and hepatorenal function. Eur J Med Res 1997, 2:419-424.
27. Kleen M, Habler O, Hutter J, Podtschaske A, Tiede M, Kemming G, Corso C, Batra S, Keipert P, Faithfull S, Messmer K. Effects of hemodilution on splanchnic perfusion and hepatorenal function. I. Splanchnic perfusion. Eur J Med Res 1997, 2:413-418.
28. Mathie RT, Ohri SK, Batten JJ, Peters AM, Keogh BE. Hepatic blood flow during cardiopulmonary bypass operations: the effect of temperature and pulsatility. J Thorac Cardiovasc Surg 1997, 114:292-293. 10.1016/S0022-5223(97)70162-4, 9270653.
29. Kramer WG, Romagnoli A. Effect of surgery and cardiopulmonary bypass on indocyanine green pharmacokinetics. Tex Heart Inst J 1986, 13:77-82. 324601, 15226835.
30. Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S. Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 2001, 29:1159-1163. 10.1097/00003246-200106000-00014, 11395594.
31. Koo DJ, Chaudry IH, Wang P. Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. J Surg Res 1999, 83:151-157. 10.1006/jsre.1999.5584, 10329110.
32. Boyle EM, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg 1997, 63:277-284. 10.1016/S0003-4975(96)01061-2, 8993292.
33. Olsson R, Hermodsson S, Roberts D, Waldenstrom J. Hepatic dysfunction after open-heart surgery. Scand J Thorac Cardiovasc Surg 1984, 18:217-222.
34. Chouker A, Martignoni A, Schauer RJ, Dugas M, Schachtner T, Kaufmann I, Setzer F, Rau HG, Lohe F, Jauch KW, Peter K, Thiel M. Alpha-gluthathione S-transferase as an early marker of hepatic ischemia/reperfusion injury after liver resection. World J Surg 2005, 29:528-534. 10.1007/s00268-004-7431-3, 15776301.
35. McSweeney ME, Garwood S, Levin J, Marino MR, Wang SX, Kardatzke D, Mangano DT, Wolman RL. Adverse gastrointestinal complications after cardiopulmonary bypass: can outcome be predicted from preoperative risk factors?. Anesth Analg 2004, 98:1610-7. table., 10.1213/01.ANE.0000113556.40345.2E, 15155313.